Abstract CT115: Phase 1b open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in combination with sintilimab (anti-PD1) in patients with advanced microsatellite stable (MSS) colorectal,gastroesophageal or ovarian cancer

Mark Wong, Jia Liu, Shehara Mendis et al.|Cancer Research|2025

Cited by 0